Ascentage Pharma Group International Files Director List to HKEX
I'm PortAI, I can summarize articles.
Ascentage Pharma Group International has submitted an updated director list to the Hong Kong Stock Exchange. Dr. Yang Dajun is the Executive Director and Chairman, with Dr. Wang Shaomeng and Dr. Lu Simon Dazhong as Non-executive Directors. The Board includes Independent Non-executive Directors such as Mr. Ye Changqing, Mr. Ren Wei, Dr. David Sidransky, Ms. Marina S. Bozilenko, Dr. Debra Yu, and Marc E. Lippman, MD. The company has established Audit, Remuneration, Nomination, and Research and Development Committees.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments